Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PHH 1V

Next Previous
Drug Profile

PHH 1V

Alternative Names: COVID-19 vaccine - Laboratorios HIPRA; HIPRA SARS-CoV-2 vaccine; PHH-1V; Recombinant protein RBD vaccine - HIPRA; SARS-CoV-2 vaccine - HIPRA

Latest Information Update: 24 Mar 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LABORATORIOS HIPRA
  • Class COVID-19 vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III COVID 2019 infections

Most Recent Events

  • 03 Mar 2023 Laboratories HIPRA completes a phase III clinical trial in COVID-2019 infections (Prevention, In adolescents, In adults, In the elderly) in Spain and Italy (IM) (NCT05246137)
  • 30 Sep 2022 Laboratorios Hipra completes a phase I/II trial in COVID-2019 infection in Spain (NCT05007509; EudraCT2021-001411-82)
  • 11 Apr 2022 LABORATORIOS HIPRA plans a phase III trial in COVID-2019 infections (Prevention, In adults, In the elderly) in Spain and Turkey (NCT05303402)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top